FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2085488918> ?p ?o ?g. }

• W2085488918 endingPage "998" @default.
• W2085488918 startingPage "989" @default.
• W2085488918 abstract "Preinvasive mammary pathologies in humans and rat chemical carcinogenesis model systems have an increased microvascular density relative to normal tissue. This suggests the possibility of preventing invasive breast cancer by inhibiting angiogenesis. Vascular endothelial cell growth factor (VEGF) is a potent angiogenic growth factor, commonly involved in tumor-induced angiogenesis. Here, we show that both VEGF and VEGFR2 expression increase with histological progression to invasive disease in the rat 7,12-dimethylbenz[a]anthracene (DMBA) model. Other VEGF receptors, VEGFR1, neuropilin 1 and neuropilin 2, are constitutively expressed throughout progression. To examine whether VEGF signaling is functionally relevant to tumor-induced endothelial tubule formation in vitro and for tumor formation in vivo, we utilized the VEGFR2 inhibitor, ZD6474. In vitro endothelial cell tubulogenesis induced by isolated mammary organoids or carcinoma in situ from DMBA-treated rats is inhibited by ZD6474, in a dose-dependent fashion. The administration of ZD6474 to DMBA-treated rats inhibits the formation of atypical ductal hyperplasia and carcinoma in situ by greater than 95% (P<0.05), when administered 1 week or 6 weeks post-DMBA initiation. Invasive disease was absent in all ZD6474 cohorts. These data support the hypothesis that progression of DMBA-induced preinvasive mammary pathologies to palpable disease requires angiogenesis via a VEGF-dependent mechanism." @default.
• W2085488918 created "2016-06-24" @default.
• W2085488918 creator A5018175584 @default.
• W2085488918 creator A5029599797 @default.
• W2085488918 creator A5048917628 @default.
• W2085488918 creator A5071665300 @default.
• W2085488918 creator A5075072604 @default.
• W2085488918 creator A5080015943 @default.
• W2085488918 date "2004-08-01" @default.
• W2085488918 modified "2023-09-29" @default.
• W2085488918 title "Inhibition of VEGFR2 prevents DMBA-induced mammary tumor formation" @default.
• W2085488918 cites W1970050679 @default.
• W2085488918 cites W1998855650 @default.
• W2085488918 cites W2008019350 @default.
• W2085488918 cites W2011020623 @default.
• W2085488918 cites W2012790616 @default.
• W2085488918 cites W2015809080 @default.
• W2085488918 cites W2022861980 @default.
• W2085488918 cites W2026621524 @default.
• W2085488918 cites W2027840164 @default.
• W2085488918 cites W2043016782 @default.
• W2085488918 cites W2045375151 @default.
• W2085488918 cites W2063391840 @default.
• W2085488918 cites W2064866979 @default.
• W2085488918 cites W2066458483 @default.
• W2085488918 cites W2067817921 @default.
• W2085488918 cites W2070230256 @default.
• W2085488918 cites W2074941277 @default.
• W2085488918 cites W2079060375 @default.
• W2085488918 cites W2080073879 @default.
• W2085488918 cites W2089723533 @default.
• W2085488918 cites W2090094486 @default.
• W2085488918 cites W2131572066 @default.
• W2085488918 cites W2158743409 @default.
• W2085488918 cites W2319962899 @default.
• W2085488918 cites W4235948748 @default.
• W2085488918 doi "https://doi.org/10.1038/labinvest.3700128" @default.
• W2085488918 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15170218" @default.
• W2085488918 hasPublicationYear "2004" @default.
• W2085488918 type Work @default.
• W2085488918 sameAs 2085488918 @default.
• W2085488918 citedByCount "28" @default.
• W2085488918 countsByYear W20854889182012 @default.
• W2085488918 countsByYear W20854889182013 @default.
• W2085488918 countsByYear W20854889182016 @default.
• W2085488918 countsByYear W20854889182019 @default.
• W2085488918 countsByYear W20854889182021 @default.
• W2085488918 countsByYear W20854889182022 @default.
• W2085488918 crossrefType "journal-article" @default.
• W2085488918 hasAuthorship W2085488918A5018175584 @default.
• W2085488918 hasAuthorship W2085488918A5029599797 @default.
• W2085488918 hasAuthorship W2085488918A5048917628 @default.
• W2085488918 hasAuthorship W2085488918A5071665300 @default.
• W2085488918 hasAuthorship W2085488918A5075072604 @default.
• W2085488918 hasAuthorship W2085488918A5080015943 @default.
• W2085488918 hasBestOaLocation W20854889181 @default.
• W2085488918 hasConcept C121608353 @default.
• W2085488918 hasConcept C126322002 @default.
• W2085488918 hasConcept C134018914 @default.
• W2085488918 hasConcept C142724271 @default.
• W2085488918 hasConcept C167734588 @default.
• W2085488918 hasConcept C2776187077 @default.
• W2085488918 hasConcept C2777025900 @default.
• W2085488918 hasConcept C2778938436 @default.
• W2085488918 hasConcept C2779256057 @default.
• W2085488918 hasConcept C2780394083 @default.
• W2085488918 hasConcept C502942594 @default.
• W2085488918 hasConcept C530470458 @default.
• W2085488918 hasConcept C555283112 @default.
• W2085488918 hasConcept C71924100 @default.
• W2085488918 hasConcept C86803240 @default.
• W2085488918 hasConceptScore W2085488918C121608353 @default.
• W2085488918 hasConceptScore W2085488918C126322002 @default.
• W2085488918 hasConceptScore W2085488918C134018914 @default.
• W2085488918 hasConceptScore W2085488918C142724271 @default.
• W2085488918 hasConceptScore W2085488918C167734588 @default.
• W2085488918 hasConceptScore W2085488918C2776187077 @default.
• W2085488918 hasConceptScore W2085488918C2777025900 @default.
• W2085488918 hasConceptScore W2085488918C2778938436 @default.
• W2085488918 hasConceptScore W2085488918C2779256057 @default.
• W2085488918 hasConceptScore W2085488918C2780394083 @default.
• W2085488918 hasConceptScore W2085488918C502942594 @default.
• W2085488918 hasConceptScore W2085488918C530470458 @default.
• W2085488918 hasConceptScore W2085488918C555283112 @default.
• W2085488918 hasConceptScore W2085488918C71924100 @default.
• W2085488918 hasConceptScore W2085488918C86803240 @default.
• W2085488918 hasIssue "8" @default.
• W2085488918 hasLocation W20854889181 @default.
• W2085488918 hasLocation W20854889182 @default.
• W2085488918 hasOpenAccess W2085488918 @default.
• W2085488918 hasPrimaryLocation W20854889181 @default.
• W2085488918 hasRelatedWork W1500013333 @default.
• W2085488918 hasRelatedWork W2008017868 @default.
• W2085488918 hasRelatedWork W2011674713 @default.
• W2085488918 hasRelatedWork W2085488918 @default.
• W2085488918 hasRelatedWork W2465742825 @default.
• W2085488918 hasRelatedWork W2487824964 @default.
• W2085488918 hasRelatedWork W3084176717 @default.

• next